National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/8/2021 release of VAERS data:

Found 5,092 cases where Vaccine is COVID19 and Manufacturer is MODERNA and Symptom is Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coagulopathy or Deep vein thrombosis or Disseminated intravascular coagulation or Embolism or Idiopathic thrombocytopenic purpura or Immune thrombocytopenia or Immune thrombocytopenic purpura or Ischaemic stroke or Myocardial infarction or Petechiae or Pulmonary embolism or Purpura or Thrombocytopenia or Thrombosis or Vasculitis



Case Details

This is page 16 out of 510

Result pages: prev   7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25   next


VAERS ID: 1015630 (history)  
Form: Version 2.0  
Age: 56.0  
Sex: Male  
Location: California  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event (No reported medical history.)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: Died of a heart attack; A spontaneous report was received from a consumer concerning a 56-year-old male patient who received Moderna''s COVID-19 Vaccine (mRNA-1273) and died due to a heart attack. The patient''s medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included additional medications. On an unknown date, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. - On an unknown date, the reporter stated the patient received Moderna''s COVID-19 vaccine and sometime after he was found dead by his bedside around 02:30 am. The patient died on an unknown date. The cause of death was due to a heart attack. Plans for autopsy were not provided.; Reporter''s Comments: This case concerns a 56 year old, male patient, who experienced fatal unexpected event of myocardial infarction. The event occurred on an unspecified date after mRNA-1273 (Lot# Unknown). Treatment details not provided. Very limited information regarding this event has been provided at this time. Based on temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Additional information has been requested.; Reported Cause(s) of Death: Unknown cause of death


VAERS ID: 1015634 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Indiana  
Vaccinated:2021-01-13
Onset:2021-01-14
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 02L20A / 1 LA / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Chills, Dyspnoea, Headache, Myocardial infarction, Pain in extremity
SMQs:, Anaphylactic reaction (broad), Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: VITAMIN D [COLECALCIFEROL]; METOPROLOL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event (No adverse event was not reported)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: Heart attack; Short breath; Headache; Chills; A spontaneous report was received from a 37 year old male patient who received Moderna''s COVID-19 vaccine (mRNA-1273) and experienced heart attack, headache, chills, and short breath. There was no medical history provided. Concomitant medications included colecalciferol and metoprolol both for unknown indications. On 13 Jan 2021, the patient received the first of two planned doses of mRNA-1273 (Batch # 02L20A), in in his left arm, for prophylaxis of COVID-19 infection. On 14 Jan 2021, the day after vaccination, the patient experienced the non-serious events of headache, chills, arm pain, and short breath. On 19 Jan 2021, six days after receiving the vaccine, the patient experienced the serious event of heart attack. Treatment included paracetamol. Action taken with mRNA-1273 in response to the events was not reported. The outcome for the events heart attack, headache, chills and short breath was unknown at the time of this report.; Reporter''s Comments: This case concerns a 37-year-old, male patient. The patient''s medical history was not provided. The patient experienced a serious, unexpected event of myocardial infarction 7days after the first dose of mRNA-1273 (Batch # 02L20A). The patient also had non serious event of headache, chills and dyspnea the day after the first dose of mRNA-1273 (Batch # 02L20A). Very limited information regarding this event has been provided at this time. Based on temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.


VAERS ID: 1015638 (history)  
Form: Version 2.0  
Age: 64.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-01-05
Onset:2021-01-26
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 037K20A / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Deep vein thrombosis, Pulmonary embolism
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event (No reported medical history.)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: Deep vein thrombosis; pulmonary embolism; A spontaneous report was received from a 64-year-old female consumer who received Moderna''s COVID-19 Vaccine (mRNA-1273) and developed deep vein thrombosis and pulmonary emboli. The patient''s medical history was not provided. Concomitant product use was not provided. On 05 Jan 2021, approximately 3 weeks prior to the onset of the events, the patient received first dose of mRNA-1273 (Lot number: 037K20A) intramuscularly for prophylaxis of COVID-19 infection. On 26 Jan 2021, the patient reported she was hospitalized for deep vein thrombosis and pulmonary emboli. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, deep vein thrombosis and pulmonary emboli, were considered unknown.; Reporter''s Comments: This case concerns a 64-year-old, female patient. The patient''s medical history was not provided. The patient experienced serious, unexpected event of Deep vein thrombosis and pulmonary embolism. The events occurred 22 days after the first dose of mRNA-1273 (Lot number: 037K20A) administration. Very limited information regarding this event has been provided at this time. Based on temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Additional information has been requested for further assessment.


VAERS ID: 1015814 (history)  
Form: Version 2.0  
Age: 54.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2021-02-04
Onset:2021-02-05
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Livedo reticularis, Pneumonia, Pulmonary embolism, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, venous (narrow), Eosinophilic pneumonia (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Aubagio, Vitamin C, Baclofen, Acetaminophen, Vitamin D3, Nystatin, Protonix, Polyethelene Glycol, Methenamine, Losartan Potassium, D-Mannose, Modafinil, Hydrocholorthiazide, Meloxicam, Furosemide, Calcium Carbonate, Melatonin, Duloxetine HC
Current Illness:
Preexisting Conditions: multiple sclerosis, Neuromuscular dysfunction of bladder, hypertension, depressive disorder,
Allergies: Lisinopril, Penicillins, Sulfa
Diagnostic Lab Data: Unknown, performed at other facility
CDC Split Type:

Write-up: Resident developed low grade fever next day and it continued through Monday morning with some mottling starting to appear on resident''s skin. Sent to ER on Monday. Resident sent to higher level of care and diagnosed with pneumonia and bilateral pulmonary embolism


VAERS ID: 1016123 (history)  
Form: Version 2.0  
Age: 38.0  
Sex: Female  
Location: Indiana  
Vaccinated:2021-02-07
Onset:2021-02-08
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 038K20A / 2 LA / SYR

Administered by: Other       Purchased by: ?
Symptoms: Arthralgia, Chills, Decreased appetite, Epistaxis, Fatigue, Headache, Injection site urticaria, Pain, Pyrexia, Thrombosis
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Hypersensitivity (narrow), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Anastrozole
Current Illness: Not applicable
Preexisting Conditions: Breast Cancer Survivor
Allergies: Not applicable
Diagnostic Lab Data:
CDC Split Type:

Write-up: Day after (2/8/21): Severe chills, tiredness, body aches, headache, loss of appetite, fever (101.4), bloody nose w/blood clots (left nostril only). 2 days after (2/9/21): Intermittent headache, aches in joints, bloody nose w/blood clots (left nostril only), hive around injection site.


VAERS ID: 1016814 (history)  
Form: Version 2.0  
Age: 27.0  
Sex: Female  
Location: New Mexico  
Vaccinated:2021-01-28
Onset:2021-01-29
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 AR / IM
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 AR / IM

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Computerised tomogram, Dyspnoea, Fibrin D dimer, Pulmonary embolism
SMQs:, Anaphylactic reaction (broad), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Drospirenone and Ethinyl Estradiol birth control
Current Illness: None
Preexisting Conditions: None
Allergies: Amoxicillin, Bactrim, Cipro, Latex, Macrobid
Diagnostic Lab Data: D dimer and CTA on 2/8/21
CDC Split Type:

Write-up: Pulmonary Embolism 27 year old female presented to ED with chest pain and shortness of breath that began within 24 hours of receiving second Covid vaccine injection on 1/29/21. Chest pain subsided with Tylenol and time, but shortness of breath persisted, worsening on 2/8/21 which brought patient to ED. CTA confirmed PE diagnosis and treated with out patient oral therapy - Xarelto.


VAERS ID: 1017227 (history)  
Form: Version 2.0  
Age: 33.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2021-02-05
Onset:2021-02-05
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 010M20A / 2 LA / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Chills, Fatigue, Headache, Injection site reaction, Lymph node pain, Lymphadenopathy, Pain, Purpura, Pyrexia, Skin warm, Swelling
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: headache, fatigue, body aches (mild-moderate)
Other Medications: NA
Current Illness: NA
Preexisting Conditions: NA
Allergies: sulfa drugs penicillins
Diagnostic Lab Data:
CDC Split Type:

Write-up: --Low grade fever (~99F) for approx. 48 hours beginning evening of vaccination (resolved as of 2/9) --Body aches, chills, extreme fatigue for approx. 60 hours beginning evening of vaccination (resolved as of 2/9) --Headache for approx. 72 hours beginning evening of vaccination (resolved as of 2/9) --Injection site reaction beginning 24 hours following vaccination, hot, swollen, red/purple rectangular area in left deltoid (resolved as of 2/9) --Painful and swollen lymph nodes in armpit on injection side arm beginning 24 hours following vaccination- lasting 72+ hours (unresolved as of 2/9)


VAERS ID: 1017512 (history)  
Form: Version 2.0  
Age: 87.0  
Sex: Female  
Location: Florida  
Vaccinated:2021-01-25
Onset:2021-01-28
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 030L20A / 1 RA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Purpura, Rash
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: levothyroxine, donepezil, memeantine, clacium, Vitamin D
Current Illness: N/A
Preexisting Conditions: Alzheimers, Hypothyroid, Osteoporosis
Allergies: N/A
Diagnostic Lab Data:
CDC Split Type:

Write-up: Purpuric lesions on lower extremities, one each leg


VAERS ID: 1017765 (history)  
Form: Version 2.0  
Age: 71.0  
Sex: Female  
Location: Arizona  
Vaccinated:2021-01-16
Onset:2021-01-20
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Acute monocytic leukaemia, Acute myeloid leukaemia, Alanine aminotransferase normal, Anaemia, Anaemia macrocytic, Aspartate aminotransferase normal, Back pain, Band neutrophil percentage, Biopsy bone marrow abnormal, Blood bilirubin normal, Blood creatinine normal, Blood culture negative, Chemotherapy, Chest X-ray, Chest pain, Computerised tomogram thorax, Computerised tomogram thorax abnormal, Dyspnoea, Endotracheal intubation, Eosinophil percentage, Fibrin D dimer increased, Haematocrit decreased, Haemoglobin decreased, Intensive care, International normalised ratio increased, Liver function test increased, Lymphocyte percentage, Malaise, Monocyte percentage, Monocytosis, Neutrophil count decreased, Neutrophil percentage decreased, Platelet count decreased, Prothrombin time prolonged, Pyrexia, Red blood cell count decreased, SARS-CoV-2 antibody test positive, SARS-CoV-2 test negative, Thrombocytopenia, Troponin normal, White blood cell count increased, White blood cell count normal
SMQs:, Liver related investigations, signs and symptoms (narrow), Liver-related coagulation and bleeding disturbances (narrow), Anaphylactic reaction (broad), Agranulocytosis (broad), Angioedema (broad), Haematopoietic cytopenias affecting more than one type of blood cell (broad), Haematopoietic erythropenia (narrow), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Malignant lymphomas (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Haematological malignant tumours (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: bupropion 300 mg daily and simvastatin 20 mg daily
Current Illness: felt healthy and hiking 3-4 miles per day previous to vaccination
Preexisting Conditions: depression, CKD stage III, hyperlipidemia, hypothyroidism, migraine, history of cervical cancer (only treatment was hysterectomy no chemotherapy or radiation)
Allergies: no known allergies
Diagnostic Lab Data: 1/28 Hgb 10.2 g/dL, Hct 29.6 %, WBC 7.0, Platelets 201 k, neutrophils 14%, Bands 0%, eosinophils 1%, lymphocytes 33%, monocytes 52%, Macrocytosis A 1+, D Dimer 747 ng/mL, PT 13.6 Sec, INR 1.2 PTT 26.6 Sec, SCr 1.08 Bili 0.2, ALT 27 u/L, AST 34 u/L, troponin <0.01 ng/ml. 1/31/2021 - WBC 13.3 k/mm3 (monocytes 7.0 K/uL neutrophils 2.0 k/uL) RBC 1.79 Hgb 6.6 g/dL Hct 19.7 % Platelets 142k/mm3. Blood cultures from 1/31/2021 are negative final. Chest xray and CT thorax in chart from 1/31/2021. Bone Marrow Biopsy on 2/1/2021 resulted as Acute myeloid leukemia with monocytic differentiation. Peripheral blood showed monocytosis with immaturity and atypsia (36%) and occasional blasts and granulocytic pelgeroid changes, macrocytic anemia, thrombocytopenia. PT 14.8 sec, D Dimer $g7650 ng/mL. SCr 1.13, AST 534, ALT 418 ALK 228 Troponin 1478 U/ LD 1478 U/L L Bilirubin 0.3 mg/Dl Covid19 test negative on 1/31/2021 though IGg positive at that time.
CDC Split Type:

Write-up: I work at medical center where patient is being treated for a new diagnosis of Acute monocytic leukemia. I was able to that the patient was vaccinated with Moderna vaccine on 1/16/2021, patient does not have the vaccination card with the Lot number so this is unknown at this time. Here are the details I see in the chart. Patient arrived on 1/30/2021 at 2100, per History and physican patient has not been feeling well for about a week and a half, and had received the moderna vaccine approximately 2 weeks prior to this time. Doctors note states about a week after first COVID vaccine she noted chest and back pain, dyspnea, high grade fevers and for this went to the ER on 1/28/21 and found to have anemia Hemoglobin 10 with normal LFTs. She was thought to have a reaction to vaccination and sent home. When her symptoms did not get better she went to ER again on 1/30 and found to have Hemoglobin down to 8 and marked LFTs elevation. Pathology evaluated elevated WBC and showed monocytosis and possible blast cells and patient transferred for further workup. per oncologist patient went to primary care about 6 months ago and had a normal CBC. Patient was started on chemotherapy for diagnosis of AML during this admission, as of 2/9/2021 patient remains inpatient, is intubated in ICU with prognosis unknown at this time.


VAERS ID: 1019303 (history)  
Form: Version 2.0  
Age: 40.0  
Sex: Female  
Location: Florida  
Vaccinated:2021-02-09
Onset:2021-02-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 031L20A / 2 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Petechiae
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: Latex rash
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient called clinic first thing Wednesday Morning 2/10/2021 and reports petechia above and below injection site.


Result pages: prev   7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=16&SYMPTOMS[]=Cerebral_venous_sinus_thrombosis_%2810083037%29&SYMPTOMS[]=Cerebral_venous_thrombosis_%2810008138%29&SYMPTOMS[]=Coagulopathy_%2810009802%29&SYMPTOMS[]=Deep_vein_thrombosis_%2810051055%29&SYMPTOMS[]=Disseminated_intravascular_coagulation_%2810013442%29&SYMPTOMS[]=Embolism_%2810061169%29&SYMPTOMS[]=Idiopathic_thrombocytopenic_purpura_%2810021245%29&SYMPTOMS[]=Immune_thrombocytopenia_%2810083842%29&SYMPTOMS[]=Immune_thrombocytopenic_purpura_%2810074667%29&SYMPTOMS[]=Ischaemic_stroke_%2810061256%29&SYMPTOMS[]=Myocardial_infarction_%2810028596%29&SYMPTOMS[]=Petechiae_%2810034754%29&SYMPTOMS[]=Pulmonary_embolism_%2810037377%29&SYMPTOMS[]=Purpura_%2810037549%29&SYMPTOMS[]=Thrombocytopenia_%2810043554%29&SYMPTOMS[]=Thrombosis_%2810043607%29&SYMPTOMS[]=Vasculitis_%2810047115%29&VAX=COVID19&VAXMAN=MODERNA

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166